Skip to Content Facebook Feature Image

Brightseed Launches the World’s First Clinically-Validated, Enterprise AI Platform, Built on Over a Decade of Scientific Research

Business

Brightseed Launches the World’s First Clinically-Validated, Enterprise AI Platform, Built on Over a Decade of Scientific Research
Business

Business

Brightseed Launches the World’s First Clinically-Validated, Enterprise AI Platform, Built on Over a Decade of Scientific Research

2026-03-25 23:00 Last Updated At:03-27 15:29

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 25, 2026--

Brightseed, Inc., the AI-native life sciences company, today announced the launch of its innovation platform — the first continuous, AI-powered health sciences innovation platform designed to increase the probability of commercial success across health and life sciences.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260325044438/en/

With this launch, Brightseed formally evolves from a discovery-focused bioactives company into a platform-based enterprise AI company delivering data-as-a-service (DaaS) to global health science organizations. The business evolution is built on the technology and learnings that has allowed Brightseed to produce the first clinically-validated, AI discovered compounds in the commercial market.

Across health and life sciences, more than 75% of early product ideas fail to reach market due to fragmented workflows, disconnected data, and late-stage risk discovery. Innovation has historically been structured as episodic project work rather than a connected, compounding capability.

Brightseed’s innovation platform rebuilds that model from the ground up. It connects discovery, development, and commercialization within a unified architecture that preserves scientific insight, evidence, and decision context across the innovation lifecycle — transforming innovation from a gamble into a strategic growth engine.

At its core is Forager™, Brightseed’s AI-powered discovery engine built on the world’s largest proprietary bioactive dataset spanning more than 11 million natural compounds across 23 health territories. Unlike general-purpose AI systems trained on public data, Brightseed’s platform is grounded in proprietary biological intelligence designed specifically for scientific rigor, traceability, and defensibility.

“Health innovation has operated on a broken probability curve for decades,” said Lee Chae, PhD, Co-Founder and Chief Executive Officer of Brightseed. “We built our innovation platform to fundamentally change that curve. By converging deep biological insight, proprietary multi-omics datasets, and cutting-edge AI and machine learning architecture into a continuous innovation foundation, we are defining a new category — one where AI is not an add-on, but the core operating foundation of life sciences innovation.”

Brightseed enters this phase with more than 40 partnerships across consumer health, nutrition, personal care, pharmaceuticals, and animal health, and is transitioning customers to a recurring subscription model aligned with its platform strategy. The company serves the $6.8 trillion global wellness market and is expanding its enterprise footprint as it prepares for its next phase of growth.

About Brightseed

Backed by over 40 industry leading partners, Brightseed® exists to empower health science teams with the foundation needed to advance science, develop better products, and ultimately transform health through AI. The Bay Area company brings together biology, the world’s largest proprietary dataset, and over a decade of computational science expertise with a shared commitment to illuminating biology and translating scientific insight into real-world impact. Brightseed’s work is guided by the belief that better health outcomes require clarity, precision, and an integrated approach to innovation.

For more information, visit brightseedbio.com.

By converging deep biological insight, proprietary multi-omics data assets, and cutting-edge AI and machine learning architecture into a continuous innovation foundation, we are defining a new category — one where AI is not an add-on, but the core operating foundation of life sciences innovation.

By converging deep biological insight, proprietary multi-omics data assets, and cutting-edge AI and machine learning architecture into a continuous innovation foundation, we are defining a new category — one where AI is not an add-on, but the core operating foundation of life sciences innovation.

NEW YORK (AP) — Kamala Harris “wrote off rural America" during the 2024 presidential campaign and failed to attack Donald Trump with sufficient “negative firepower," according to a long-awaited post-election autopsy released on Thursday by the Democratic National Committee.

The committee's chair, Ken Martin, shared the 192-page report only after facing intense internal pressure from frustrated Democratic operatives concerned with his leadership. Martin had originally promised to release the autopsy, only to keep it under wraps for months because he was concerned it would be a distraction ahead of the midterms as Democrats mobilize to take back control of Congress.

On Tuesday, Martin apologized for his handling of the situation and conceded that the report was withheld because it “was not ready for primetime."

Although the autopsy criticizes Democrats' focus on “identity politics,” it sidesteps some of the most controversial elements of the 2024 campaign. The report does not address former President Joe Biden’s decision to seek reelection, the rushed selection of Harris to replace him on the ticket or the party's acrimonious divide over the war in Gaza.

“I am not proud of this product; it does not meet my standards, and it won’t meet your standards,” Martin wrote in an essay on Substack on Thursday. “I don’t endorse what’s in this report, or what’s left out of it. I could not in good faith put the DNC’s stamp of approval on it. But transparency is paramount.”

A spokesperson for Harris did not immediately respond to a request for comment.

The initial reaction from Democratic operatives was a mix of bafflement and anger over Martin's handling of the situation.

“Why not say this in 2024, or bring in more people to finish it, instead of turning this into the dumbest media cycle for 7-8 months?” Democratic strategist Steve Schale wrote on social media.

The postelection report, which was authored by Democratic consultant Paul Rivera, calls for “a renewed focus on the voters of Middle America and the South, who have come to believe they are not included in the Democratic vision of a stronger and more dynamic America for everyone.”

“Millions of Americans are suffering from poor access to healthcare, manufacturing and job losses, and a failing infrastructure, yet continue to be persuaded to vote against their best interests because they do not see themselves reflected in the America of the Democratic Party,” the report says.

The autopsy points to a reduction in support and training for Democratic state parties, voter registration shifts and “a persistent inability or unwillingness to listen to all voters.”

Thursday's release comes as Martin confronts a crisis of confidence among party officials who are increasingly concerned about the health of their political machine barely a year into his term. Some Democratic operatives have had informal discussions about recruiting a new chair, even though most believe that Martin’s job wasn't in serious jeopardy ahead of the midterm elections.

The report found that Harris and her allies failed to focus enough on Trump's negatives, especially his felony convictions. This was part of a broader criticism that Democrats' messaging is too focused on reason and winning arguments, “even in cycles when the electorate is defined by rage.”

“There was a decision in the 2024 Democratic leadership not to engage in negative advertising at the scale required,” the report states. “The Trump campaign and supportive Super PACs went full throttle against Vice President Harris, but there was not sufficient or similar negative firepower directed at Trump by Democrats.”

The report continues: “It was essential to prosecute a more effective case as to why Trump should have been disqualified from ever again taking office. The grounds were there, but the messaging did not make the case.”

Trump's attack on Harris' transgender policies were cited as a key contrast.

Specifically, the report suggested the Democratic nominee was “boxed” in by the Trump campaign's “very effective” ad that highlighted Harris' previous statement of support for taxpayer-funded gender-affirming surgeries for prison inmates.

Democratic pollsters believed that “if the Vice President would not change her position – and she did not – then there was nothing which would have worked as a response," the report said.

The report criticized Harris' outreach to key segments of America while condemning the party's focus on “identity politics.”

“Harris wrote off rural America, assuming urban/suburban margins would compensate. The math doesn’t work,” the report says. “You can’t lose rural areas by overwhelming margins and make it up elsewhere when rural voters are a significant share of the electorate. If Democrats are to reclaim leadership in the Heartland or the South, candidates must perform well in rural turf. Show up, listen, and then do it again.”

The report also references Democrats' underperformance with male voters of color.

“Male voters require direct engagement. The gender gap can be narrowed. Deploy male messengers, address economic concerns, and don’t assume identity politics will hold male voters of color,” it says.

President Donald Trump speaks during an event about loosening a federal refrigerant rule, in the Oval Office at the White House, Thursday, May 21, 2026, in Washington. (AP Photo/Jacquelyn Martin)

President Donald Trump speaks during an event about loosening a federal refrigerant rule, in the Oval Office at the White House, Thursday, May 21, 2026, in Washington. (AP Photo/Jacquelyn Martin)

Former Vice President Kamala Harris speaks during a fireside chat on Thursday, May 7, 2026, in Las Vegas. (AP Photo/Ty ONeil)

Former Vice President Kamala Harris speaks during a fireside chat on Thursday, May 7, 2026, in Las Vegas. (AP Photo/Ty ONeil)

FILE - Democratic National Committee chair Ken Martin speaks during an interview with The Associated Press at DNC headquarters, Jan. 12, 2026, in Washington. (AP Photo/Allison Robbert, File)

FILE - Democratic National Committee chair Ken Martin speaks during an interview with The Associated Press at DNC headquarters, Jan. 12, 2026, in Washington. (AP Photo/Allison Robbert, File)

Recommended Articles